Primary Membranous Nephropathy clinical trials in New York
7 active Primary Membranous Nephropathy trials with a site in New York. Describe your situation to see which ones you may be eligible for.
- A Study to Assess the Effect of Surovatamig in Adult Participants With Antibody-mediated Kidney Disease
- A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
- Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
- A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
- A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
- Belimumab With Rituximab for Primary Membranous Nephropathy
- A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.